Under the acquisition, DiscoveRx will add BioSeek’s BioMAP drug screening platform to its drug discovery solutions portfolio which includes GPCR, Kinase, and NHR assay solutions and KINOMEscan technology.
Total revenues for third quarter of 2012 were $854,696 compared to $2.64m for the third quarter of 2011. The company reported a net loss attributable to the company
The new amplified process that included the optimization of the growth conditions and reduction of open manipulation steps will enable huge production of live cells. Pluristem chairman and
The new service will help its clients, entering for formulation development, to enhance oral bioavailability of their BCS II and IV compounds. Several pharmaceutical companies face solubility challenges
Trastuzumab Emtansine is designed to treat people with HER2-positive, unresectable locally advanced or metastatic breast cancer who have received prior treatment with Herceptin and a taxane chemotherapy. European
Acetadote is a drug used to minimize liver damage from acetaminophen overdoses in hospital emergency rooms. The new patent that covers the use of 200mg/ml Acetadote formulation provides
The new App, with one button click, allows researchers to identify DAB-labeled tissue, measure the integrated optical density of the stained area, output an annotated image and export
Around 1,000 patients from six countries will participate in the five-year Phase III trial. The pharmaceutical company will leverage the technology platform to accomplish the reduction in time
As a result of the modification, the Collaboration Agreement will terminate no later than 24 April 2013 and the companies will continue to perform all the obligations as
The time to beginning of symptom relief was the primary endpoint of the study that assessed the safety and efficacy profile of Ruconest (recombinant human C1 esterase inhibitor)
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.